Thank you for signing up for The Pipeline. You will stay up to date on the latest and greatest in type 1 diabetes (T1D) science with our dedicated newsletter. Every month, you’ll get the most important updates in current T1D research, information on recruiting clinical trials, therapy approvals, advances in technology, and more.